(Updated - May 28, 2026 3:43 AM EDT)

Barclays analyst Lukas Shumway initiates coverage on Cellectis (NASDAQ: CLLS) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE